论文部分内容阅读
目的:观察左氧氟沙星联合替硝唑治疗盆腔炎的临床效果。方法:选取我院2015年12月~2016年12月收治的32例盆腔炎患者,按照患者入院尾号的奇偶数,将患者分成观察组和对照组,各16例。观察组给予左氧氟沙星联合替硝唑治疗,对照组给予甲硝唑联合氧氟沙星治疗,比较两组临床疗效、不良反应和C反应蛋白检测情况。结果:观察组和对照组的治疗总有效率、不良反应发生率分别为:93.75%、6.25%,62.5%、50%,组间比较,差异性显著,具有对比的意义,P<0.05。治疗后,对比两组C反应蛋白水平,差异存在统计学意义,P<0.05。结论:盆腔炎通过左氧氟沙星、替硝唑联合治疗,临床疗效确切,并能改善患者的炎症反应,控制不良反应发生率。
Objective: To observe the clinical effect of levofloxacin and tinidazole in the treatment of pelvic inflammatory disease. Methods: Thirty-two cases of pelvic inflammatory disease admitted from December 2015 to December 2016 in our hospital were divided into observation group and control group according to the even and odd numbers of patients’ admission tail number. The observation group was treated with levofloxacin and tinidazole. The control group was treated with metronidazole and ofloxacin. The clinical efficacy, adverse reactions and C-reactive protein were compared between the two groups. Results: The total effective rate and the adverse reaction rate of the observation group and the control group were 93.75%, 6.25%, 62.5% and 50% respectively. There was significant difference between the two groups (P <0.05). After treatment, comparing the two groups of C-reactive protein levels, the difference was statistically significant, P <0.05. Conclusion: Pelvic inflammatory disease through levofloxacin and tinidazole combined treatment, clinical curative effect is exact, and can improve the patient’s inflammatory response, control the incidence of adverse reactions.